PeptiDream Stock

PeptiDream Liabilities 2024

PeptiDream Liabilities

29.11 B JPY

Ticker

4587.T

ISIN

JP3836750004

WKN

A1W0KK

In 2024, PeptiDream's total liabilities amounted to 29.11 B JPY, a -8.51% difference from the 31.82 B JPY total liabilities in the previous year.

PeptiDream Aktienanalyse

What does PeptiDream do?

PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing PeptiDream's Liabilities

PeptiDream's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating PeptiDream's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing PeptiDream's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

PeptiDream's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in PeptiDream’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about PeptiDream stock

What is the level of liabilities of PeptiDream this year?

PeptiDream has a debt balance of 29.11 B JPY this year.

What were the liabilities of PeptiDream compared to the previous year?

The liabilities of PeptiDream have increased by -8.51% dropped compared to the previous year.

What are the consequences of high debt for investors of PeptiDream?

High liabilities can pose a risk for investors of PeptiDream, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in PeptiDream?

Low liabilities mean that PeptiDream has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of PeptiDream affect the company?

An increase in liabilities of PeptiDream can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of PeptiDream affect the company?

A decrease in the liabilities of PeptiDream can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of PeptiDream?

Some factors that can influence the liabilities of PeptiDream include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of PeptiDream so important for investors?

The liabilities of PeptiDream are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can PeptiDream take to modify the liabilities?

To change its liabilities, PeptiDream can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does PeptiDream pay?

Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.

What is the dividend yield of PeptiDream?

The current dividend yield of PeptiDream is .

When does PeptiDream pay dividends?

PeptiDream pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PeptiDream?

PeptiDream paid dividends every year for the past 0 years.

What is the dividend of PeptiDream?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is PeptiDream located?

PeptiDream is assigned to the 'Health' sector.

Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PeptiDream from 12/14/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 12/14/2024.

When did PeptiDream pay the last dividend?

The last dividend was paid out on 12/14/2024.

What was the dividend of PeptiDream in the year 2023?

In the year 2023, PeptiDream distributed 0 JPY as dividends.

In which currency does PeptiDream pay out the dividend?

The dividends of PeptiDream are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PeptiDream

Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.